SCHEMBL7500228

SCHEMBL7500228

CO[C@H]1OC(=O)C[C@H]2[C@@H]1[C@H](O)[C@H]1OC(=O)[C@@]3(C)CCC[C@@]2(C)[C@@H]13

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7496026 0.67 JUN (0.38) —
SCHEMBL7488501 0.60 JUN (0.42) —
SCHEMBL9673386 0.56 TK1 (0.30) —
SCHEMBL13424257 0.55 SMN1; SMN2 (0.42) —
SCHEMBL13776551 0.55 — —
SCHEMBL16260941 0.54 ALDH1A1 (0.43) —
SCHEMBL25220377 0.53 — —
SCHEMBL8286747 0.53 — —
SCHEMBL25261658 0.53 — —
SCHEMBL21742805 0.53 ALDH1A1 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0933373-B1 Terpenoid lactone compounds and their production process PFIZER (US) 2002-06-05 — — EP disclosed
US-6391616-B1 FUNGAL CULTURE FOR USE IN TREATMENT OF INFLAMMATORY AND IMMUNOLOGICAL DEFECTS PFIZER INC. 2002-05-21 — — US disclosed
US-6225339-B1 FOR THERAPY OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, ENDOTOXEMIA AND/OR TOXIC SHOCK SYNDROME, ACUTE OR CHRONIC INFLAMMATORY DISEASE STATES SUCH AS INFLAMMATORY BOWEL DISEASE; TUBERCULOSIS, ATHEROSCLEROSIS, MUSCLE DEGENERATION, PFIZER INC. 2001-05-01 — — US disclosed
US-6221899-B1 RHEUMATIC DISORDERS; ANTIINFLAMMATORY AGENTS; BONE DISORDERS PFIZER INC. 2001-04-24 — — US disclosed
EP-0933373-A1 Terpenoid lactone compounds and their production process PFIZER INC. (US) 1999-08-04 — — EP disclosed
Send feedback